相关实验视频

Updated: Jul 16, 2025

Author Spotlight: The Significance of Isolation, Culture, and Adipogenic Induction of SVF-Derived Preadipocytes from Mouse Perivascular Adipose Tissue

Author Spotlight: The Significance of Isolation, Culture, and Adipogenic Induction of SVF-Derived Preadipocytes from Mouse Perivascular Adipose Tissue

Published on: July 21, 2023

脂肪组织作为阿尔茨海默氏症疾病中血管损伤的治疗点

Miriam Bettinetti-Luque¹, Laura Trujillo-Estrada^1,2, Eduardo Garcia-Fuentes^3,4

¹Departamento de Biología Celular, Genética y Fisiología, Instituto de Investigación Biomédica de Málaga (IBIMA)-Plataforma BIONAND, Facultad de Ciencias, Universidad de Málaga, Málaga, Spain.

British journal of pharmacology

|September 14, 2023

概括

脂肪组织通过adipokines影响大脑功能和阿尔茨海默病的发展. 本综述探讨了阿迪波金对血脑屏障的影响及其对认知衰退的治疗潜力.

科学领域:

内分泌学在内分泌学.
神经科学是一个神经科学.
免疫学免疫学免疫学

背景情况:

脂肪组织是一种内分泌器官,对能量代谢和免疫反应至关重要.
新出现的证据凸显了脂肪组织和大脑之间的关键交叉声.
脂肪组织在阿尔茨海默氏症 (AD) 等与年龄有关的疾病中的作用正在调查中.

研究的目的:

审查阿迪波金对血脑屏障 (BBB) 生理学的影响.
为了检查阿迪波金对阿尔茨海默病病因的贡献.
讨论adipokines在神经疾病中的治疗潜力.

主要方法:

对阿迪波金,BBB功能和阿尔茨海默病的研究进行文献综述.
通过adipokines影响大脑健康的机制的分析.
对基于阿迪波金的治疗策略进行当前研究的综合.

主要成果:

阿迪波金可以穿越BBB或调节其功能,影响大脑平衡.
特定的阿迪波金与阿尔茨海默病的发展和进展有关.
阿迪波基因为新型治疗干预提供了潜在的目标.

结论:

脂肪组织通过adipokine信号传递在大脑健康和疾病中发挥着重要作用.
了解阿迪波金-BBB相互作用对于神经退行性疾病研究至关重要.
向阿迪波金可能为治疗阿尔茨海默病和相关认知障碍提供新的途径.

关键词:

阿尔茨海默病的疾病阿尔茨海默病的疾病.亚迪波基因 (Adipokine) 是一种可靠的药物.脂肪组织的脂肪组织.氨基化物氨基化物这是一种炎症炎症炎症炎症.知道的知道的知道的血管血管血管血管

更多相关视频

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues

Published on: June 3, 2019

Assessment of Human Adipose Tissue Microvascular Function Using Videomicroscopy

Assessment of Human Adipose Tissue Microvascular Function Using Videomicroscopy

Published on: September 29, 2017

相关概念视频

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...